S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Best Bear Market Funds: Top 3 Investment Options to Consider
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
Merck, Cintas rise; GameStop, MiMedx fall, Wednesday, 3/27/2024
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Best Bear Market Funds: Top 3 Investment Options to Consider
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
Merck, Cintas rise; GameStop, MiMedx fall, Wednesday, 3/27/2024
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Best Bear Market Funds: Top 3 Investment Options to Consider
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
Merck, Cintas rise; GameStop, MiMedx fall, Wednesday, 3/27/2024
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Best Bear Market Funds: Top 3 Investment Options to Consider
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
Merck, Cintas rise; GameStop, MiMedx fall, Wednesday, 3/27/2024
NASDAQ:HYPR

Hyperfine (HYPR) Stock Price, News & Analysis

$1.00
-0.07 (-6.54%)
(As of 03/27/2024 ET)
Today's Range
$0.99
$1.08
50-Day Range
$0.96
$1.25
52-Week Range
$0.91
$3.28
Volume
187,370 shs
Average Volume
121,950 shs
Market Capitalization
$71.60 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.12

Hyperfine MarketRank™ Stock Analysis

Analyst Rating
Hold
2.33 Rating Score
Upside/​Downside
111.7% Upside
$2.12 Price Target
Short Interest
Bearish
2.64% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.19mentions of Hyperfine in the last 14 days
Based on 12 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Decreasing
From ($0.59) to ($0.61) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.43 out of 5 stars

Medical Sector

748th out of 939 stocks

Electromedical Equipment Industry

15th out of 20 stocks

HYPR stock logo

About Hyperfine Stock (NASDAQ:HYPR)

Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products. Its products include Swoop Portable MR imaging system, which offers neuroimaging at the point of care. The company was incorporated in 2014 and is based in Guilford, Connecticut.

HYPR Stock Price History

HYPR Stock News Headlines

The AI Defense Stock Set to Soar
To protect our interests, The Pentagon has partnered with this small AI defense contractor - creating some of the most powerful AI defenses ever made.
Recap: Hyperfine Q4 Earnings
the most reliable asset on earth is making a comeback
Global tensions have been pushing the price of gold to all time highs… Just recently, gold peaked at a record $2,000 (and is now closer to $2,200). And there’s something else critical at play right now in the world’s largest asset. Because of these critical factors, a lot of massive investment institutions are now pumping more money into gold. And as we speak, some are even calling for a massive rally in the precious metal.
Hyperfine Inc Class A HYPR
HYPR/USD - Hypr Network US Dollar
Hyperfine earnings: here's what Wall Street expects
See More Headlines
Receive HYPR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hyperfine and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
3/28/2024
Next Earnings (Estimated)
5/09/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical equipment
Sub-Industry
N/A
Current Symbol
NASDAQ:HYPR
Fax
N/A
Employees
136
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$2.12
High Stock Price Target
$3.50
Low Stock Price Target
$1.25
Potential Upside/Downside
+111.7%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
3 Analysts

Profitability

Net Income
$-44,240,000.00
Net Margins
-401.00%
Pretax Margin
-401.00%

Debt

Sales & Book Value

Annual Sales
$11.03 million
Book Value
$1.75 per share

Miscellaneous

Free Float
52,626,000
Market Cap
$71.60 million
Optionable
Optionable
Beta
0.78
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. R. Scott Huennekens CPA (Age 60)
    M.B.A., Executive Chairman
    Comp: $1.29M
  • Ms. Maria Sainz (Age 58)
    CEO, President & Director
    Comp: $340.24k
  • Dr. Jonathan M. Rothberg Ph.D. (Age 60)
    Founder & Vice Chairman
    Comp: $51.37k
  • Mr. Brett Hale (Age 50)
    Chief Administrative Officer, CFO, Chief Compliance Officer, Treasurer & Corporate Secretary
  • Dr. Tom Teisseyre Ph.D.
    Chief Operating Officer
  • Mr. Chip Truwit FACR
    M.D., Vice President of Scientific Affairs

HYPR Stock Analysis - Frequently Asked Questions

Should I buy or sell Hyperfine stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Hyperfine in the last twelve months. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" HYPR shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HYPR, but not buy additional shares or sell existing shares.
View HYPR analyst ratings
or view top-rated stocks.

What is Hyperfine's stock price target for 2024?

3 brokerages have issued 12 month target prices for Hyperfine's shares. Their HYPR share price targets range from $1.25 to $3.50. On average, they predict the company's share price to reach $2.12 in the next year. This suggests a possible upside of 111.7% from the stock's current price.
View analysts price targets for HYPR
or view top-rated stocks among Wall Street analysts.

How have HYPR shares performed in 2024?

Hyperfine's stock was trading at $1.12 on January 1st, 2024. Since then, HYPR stock has decreased by 10.7% and is now trading at $1.00.
View the best growth stocks for 2024 here
.

When is Hyperfine's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our HYPR earnings forecast
.

What guidance has Hyperfine issued on next quarter's earnings?

Hyperfine issued an update on its FY 2024 earnings guidance on Thursday, March, 21st. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $12.0 million-$15.0 million, compared to the consensus revenue estimate of $18.4 million.

Who are Hyperfine's major shareholders?

Hyperfine's stock is owned by a variety of retail and institutional investors. Top institutional investors include Virtu Financial LLC (0.11%), Journey Strategic Wealth LLC (0.10%), Citadel Advisors LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Alok Gupta, Hc Sponsor Llc, Jonathan M Rothberg, Khan Siddiqui, Maria Sainz, Neela Paykel and Thomas Teisseyre.
View institutional ownership trends
.

How do I buy shares of Hyperfine?

Shares of HYPR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:HYPR) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners